AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells

Donghwa Kim(Seoul National University), Sang Kook Lee(Seoul National University)
Cell Death and Disease
May 1, 2019
Cited by 98


Related Papers